Source link : https://newshealth.biz/health-news/obi-rivals-iv-isatuximab-ups-patient-comfort/
TOPLINE: A novel, single-use on-body injector (OBI) for isatuximab in multiple myeloma is noninferior to the standard intravenous (IV) formulation in efficacy and pharmacokinetics and has no unexpected safety signals. METHODOLOGY: IRAKLIA is an ongoing study of administration methods of isatuximab as part of a triplet regimen that includes pomalidomide and dexamethasone, commonly used to […]
The post OBI Rivals IV Isatuximab, Ups Patient Comfort first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-16 12:28:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8